About the doctor
Dr. José Fermín Celma Simón
General Surgeon · Specialist in Stem Cell Therapy · Puebla, Mexico
Dr. José Fermín Celma Simón is a Mexican medical doctor and general surgeon with a professional focus on regenerative medicine and stem cell therapy.
He is based in Puebla, Mexico, where he works at 50 Doctors Hospital, focusing on the application of mesenchymal stem cell therapy and innovative regenerative approaches to improve patients' quality of life.
In his own words: "I work within a hospital setting in Puebla, where I administer stem cell treatments for a range of medical conditions, including autism, Parkinson's disease, Alzheimer's disease, dementia, liver disease, diabetes, osteoarthritis, revascularisation of ischaemic limbs in systemic sclerosis, lupus, chronic obstructive pulmonary disease, stroke, leukaemia, systemic joint disease and systemic juvenile idiopathic arthritis in children."
He exclusively uses mesenchymal stem cells (MSCs) from umbilical cord donors who have not taken COVID-19 vaccines and who test negative for spike protein.
Education and experience
From medical school to regenerative medicine
A surgical background, combined with a particular interest in emerging regenerative technologies.
-
1998 – 2005
Medical studies
Universidad Popular Autónoma del Estado de Puebla (UPAEP)
-
2005 – 2006
General surgery
General Hospital of Tabasco, Mexico
-
2006 – 2007
Medical internship
-
General surgeon
Zacatlán, Puebla, Mexico
Professional medical practice in general surgery.
-
Today
50 Doctors Hospital, Puebla, Mexico
General surgeon, stem cell therapy and regenerative medicine.
Professional focus
Mesenchymal stem cell therapy
Dr. Celma has developed a particular interest in regenerative medicine, especially mesenchymal stem cell (MSC) therapy. His professional interests include exploring the potential applications of stem cells in four groups of conditions.
Neurological
Including autism, Parkinson's disease, dementia and stroke.
Autoimmune
Including type 1 diabetes, lupus and juvenile idiopathic arthritis.
Inflammatory
Conditions in which chronic inflammation plays a central role.
Degenerative
Including osteoarthritis and systemic joint disease.
His approach combines his surgical background with an interest in emerging regenerative technologies, personalised patient care and innovative therapeutic possibilities.
Patient safety
My approach to donor screening and patient safety
For me, comprehensive donor screening, rigorous laboratory testing, transparency and independently verifiable documentation are fundamental requirements when preparing stem cells for patient administration.
I have particular requirements concerning donor selection and the presence of SARS-CoV-2 spike protein. In view of the potential concerns associated with spike protein following COVID-19 vaccination, I have established a donor selection process in which the stem cells used for my patients must come from donors who test negative for detectable spike protein. This is an important consideration for me and for many of my patients.
Every patient receives a Certificate of Analysis, together with supporting laboratory documentation identifying the specific assays performed, the results obtained and the testing procedures used for the stem cells being administered.
Professional mission
Professional mission
"To contribute to the advancement of regenerative medicine by bringing innovative therapeutic approaches to patients in Mexico and internationally, with a commitment to medical practice, continuous learning and improving quality of life."
Raising standards across the field
I would particularly like to see greater collaboration between doctors, independent laboratories and researchers to establish consistent approaches to donor screening, cell characterisation, potency testing and quality assurance.
Progress in medicine depends not only on developing new treatments but also on continually improving how those treatments are prepared, assessed and administered. I do not believe these standards should be unique to my practice. I hope they will encourage discussion among other medical professionals and, ultimately, inspire wider adoption throughout the stem cell community.
My hope is simple: greater transparency, better laboratory accountability and higher standards across the entire field of stem cell medicine. This is about raising standards, sharing knowledge and putting professional responsibility at the centre of everything we do.Dr. Fermín Celma
Stem cell therapy is not a magic cure, but for many patients it offers a real possibility of improvement. I share my clinical experience openly, including the challenges, in my articles and videos.
Contact Dr. Celma
If you contact me regarding treatment, I will reply to you personally by email. I usually have a waiting list, so my first reply can take seven to ten days.